Reuters: Roche's $46.8 billion Genentech deal outshines others

[dave]

Roche's $46.8 billion Genentech deal outshines others
      
   
      

ZURICH (Reuters) - It is buying up less than half of Genentech Inc for a whopping $46.8 billion, but Switzerland's Roche Holding AG may have clinched the best of this year's three big drug deals.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login